Search clinical trials for: Placebo of Rifaximin
Total 183977 results
-
National Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Puerto Rico, Switzerland
-
University of PittsburghCompleted
-
National Cancer Institute (NCI)Recruiting
-
National Cancer Institute (NCI)RecruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric... and other conditionsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMedulloblastoma | Anaplastic MedulloblastomaUnited States, Canada, Puerto Rico, Australia, Netherlands
-
Mayo ClinicNational Cancer Institute (NCI)Not yet recruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Locally Advanced Pancreatic Adenocarcinoma | Unresectable Pancreatic AdenocarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingHelicobacter Pylori InfectionChina
-
Atlantic Health SystemColumbia UniversityRecruiting
-
The Aurum Institute NPCJohns Hopkins UniversityRecruitingTuberculosis | HIV Seropositivity | Household ContactSouth Africa, India, Indonesia, Mozambique
-
Xuanzhu Biopharmaceutical Co., Ltd.Recruiting
-
Janssen Pharmaceutical K.K.RecruitingTreatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)Taiwan, Korea, Republic of, Japan
-
Jonsson Comprehensive Cancer CenterMirati Therapeutics Inc.; Phase One FoundationRecruitingRhabdomyosarcomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma
-
National Cancer Institute (NCI)Active, not recruitingAstrocytoma, IDH-Mutant, Grade 2 | Astrocytoma, IDH-Mutant, Grade 3United States
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | Recurrent GlioblastomaUnited States
-
Mannkind CorporationJaeb Center for Health ResearchActive, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
Ping-I (William) Hsu, M.D.CompletedHelicobacter Pylori InfectionTaiwan
-
HIV Prevention Trials NetworkGilead SciencesActive, not recruitingHIV PreventionUnited States, Brazil
-
M.D. Anderson Cancer CenterCompletedMyocarditis AcuteUnited States
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1United States
-
Institute of Child HealthCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Glioblastoma | Recurrent Gliosarcoma | Malignant Supratentorial NeoplasmUnited States
-
University of FloridaPatient-Centered Outcomes Research Institute; Merck Sharp & Dohme LLC; AbbVieCompleted
-
Johns Hopkins UniversityGilead SciencesCompleted
-
University of California, DavisSanofiTerminatedHormone-Resistant Prostate Cancer | Stage IV Prostate AdenocarcinomaUnited States
-
Zeynep YurdakulUnknown
-
Kaohsiung Veterans General Hospital.UnknownHelicobacter Pylori InfectionTaiwan
-
Istanbul Training and Research HospitalWithdrawnContraceptive Methods ComparisonTurkey
-
Mayo ClinicNational Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRecurrent Chronic Lymphocytic LeukemiaUnited States
-
University of MonastirCompletedSepsis | Chronic Obstructive Pulmonary Disease | Antibiotics
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Uterine Corpus Sarcoma | Uterine CarcinosarcomaUnited States
-
Global Alliance for TB Drug DevelopmentCompletedPulmonary TuberculosisSouth Africa
-
Statens Serum InstitutBill and Melinda Gates Foundation; Larix A/S; CCBR Clinical ResearchCompletedImmunization, BoosterDenmark
-
University of ChicagoNational Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Adult Acute Myeloid Leukemia... and other conditionsUnited States
-
St. Stephens Clinical ResearchCompleted
-
St Stephens Aids TrustMylan Inc.Completed
-
University College, LondonCompleted
-
University of BamendaMinistry of Science and Technology of the People´s Republic of China; National...CompletedDrug Resistant Malaria Due to Plasmodium FalciparumCameroon
-
McGill University Health Centre/Research Institute...Merck Sharp & Dohme LLC; CIHR Canadian HIV Trials NetworkCompletedHepatitis C | HIV | Liver FibrosisCanada
-
ActelionCompleted
-
Juan A. ArnaizUnknownPatient Compliance | Antiretroviral Therapy IntoleranceSpain
-
Makerere UniversityCompleted
-
Frank LippertThe Borrow FoundationCompleted
-
University of PittsburghWithdrawnHyperparathyroidism | Osteoporosis | Bone Diseases, Endocrine | Hypercalcemia of MalignancyUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States